Seattle Children's Hospital (DBA Seattle Children's Research Institute);University of Washington
发明人:
申请号：
EP15776501.7
公开号：
EP3129480A4
申请日:
2015.04.08
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention provides nucleic acids, vectors, host cells, methods and compositions to confer and/or augment immune responses mediated by cellular immunotherapy, such as by adoptively transferring CD8+ central memory T cells or combinations of central memory T cells with CD4+ T cells that are genetically modified to express a chimeric receptor. In some alternatives the genetically modified host cell comprises a nucleic acid comprising a polynucleotide coding for a ligand binding domain, a poly nucleotide comprising a customized spacer region, a polynucleotide comprising a transmembrane domain, and a polynucleotide comprising an intracellular signaling domain. In some alternatives, the ligand binding domains binds to CD171.
